NJ MPJE study materials
NJ MPJE study resources

NJ MPJE: Patient Safety, Error Reporting, and the Prescription Monitoring Program

NJ MPJE · Work through your exam, one topic at a time.

All guide sections

Patient Safety, Error Reporting, and the Prescription Monitoring Program

Internal safety systems

Pharmacies are expected to operate a continuous quality improvement program: a defined process for identifying, documenting, and analyzing medication errors and near misses, with corrective action that changes the system rather than blaming an individual. Look-alike/sound-alike drug selection, tall-man lettering, independent double checks for high-alert medications, workflow separation for confusing products, and error-trigger reports are the usual tools. Documentation of the review, not just the event, is what a surveyor or examiner looks for.

External reporting

Report serious events externally per the applicable program - New Jersey's patient safety reporting framework for preventable adverse events, and MedWatch for product problems and serious adverse drug events (voluntary for practitioners, mandatory for manufacturers). Controlled substance theft or significant loss goes to DEA, and state notification obligations run in parallel. Reports go to the right agency; sending an event to the wrong one does not satisfy the obligation.

Prescription monitoring

Pharmacies must report each dispensed controlled substance to the New Jersey Prescription Monitoring Program on the required schedule, using accurate patient, prescriber, drug, quantity, and date data. Prescribers must query the PMP in defined opioid situations; pharmacists query it as part of corresponding responsibility when risk indicators appear - early refills, multiple prescribers, multiple pharmacies, cash payment, out-of-area travel. PMP information is confidential; access is limited to authorized purposes and delegate access must be properly established.

Traps

A near miss still belongs in the internal quality record even though it triggers no external report. Failing to report a dispensing to the PMP is a separate violation from failing to review it. The pharmacist, not a technician, owns the corresponding-responsibility judgment.

Rule of thumb: internal for near misses, external for harm, PMP for every controlled substance dispensed.